"Thrombocytosis" Natural Recordings by Native Speakers
Thrombocytosis is a medical condition characterized by an abnormally high platelet count in the blood. Platelets, also known as thrombocytes, are a type of blood cell that plays a crucial role in blood clotting.
There are two main types of thrombocytosis:
1. Essential thrombocytosis: Also known as primary thrombocytosis, this is a rare genetic disorder that affects the production of platelets, leading to an unstable platelet count.
2. Reactive thrombocytosis: This is a secondary condition that occurs in response to an underlying medical condition, such as an infection, inflammation, trauma, or cancer.
Symptoms of thrombocytosis may include:
Headaches
Dizziness or lightheadedness
Fatigue
Bleeding or bruising easily
Abdominal pain
Joint pain
If left untreated, thrombocytosis can increase the risk of blood clots, which can lead to serious complications, such as stroke, heart attack, or pulmonary embolism. Treatment typically involves medications that help reduce platelet count and prevent blood clots.
Relating to platelets, especially those that cause thrombosis or the formation of blood clots.
Thrombocytopaenia, also known as thrombocytopenia, is a condition characterized by an abnormally low level of platelets in the blood. Platelets are small blood cells that play a crucial role in blood clotting and stopping bleeding when a blood vessel is injured.
Thrombocytopaenic refers to a medical condition characterized by a low platelet count (thrombocytopenia).
A thrombocytopenia is a condition characterized by low platelet count below the normal level, with a platelet count below 150,000.
Thrombocytopenia is a medical condition characterized by an abnormally low level of platelets in the blood. Platelets, also known as thrombocytes, are small blood cells that play a crucial role in blood clotting and preventing bleeding. Thrombocytopenia can cause symptoms such as easy bruising, excessive bleeding, and petechiae (small red or purple spots on the skin).<br><br>Thrombocytopenia can be caused by a variety of factors, including:<br><br>1. Bone marrow problems: Certain medications, chemotherapy, and radiation therapy can damage the bone marrow and reduce platelet production.<br>2. Infections: Certain infections, such as HIV, can suppress the bone marrow and lead to thrombocytopenia.<br>3. Autoimmune disorders: Autoimmune disorders, such as lupus or rheumatoid arthritis, can cause the body to attack and destroy platelets.<br>4. Vitamin deficiencies: Deficiencies in vitamins C and B12 can lead to thrombocytopenia.<br>5. Medication side effects: Certain medications, such as aspirin, heparin, and certain antibiotics, can reduce platelet count.<br><br>Treatment for thrombocytopenia depends on the underlying cause and can include medications, such as corticosteroids or immunoglobulins, to stimulate platelet production, and blood transfusions in severe cases.
Thrombocytopenias refer to a medical condition characterized by a low platelet count in the blood. Platelets are small cells that play a crucial role in blood clotting and preventing excessive bleeding when a blood vessel is injured. With thrombocytopenia, the body either produces too few platelets or destroys them at an accelerated rate, which can lead to various symptoms such as:<br><br>1. <strong>Increased risk of bleeding:</strong> This is the primary concern with thrombocytopenia. People with low platelet counts are at a higher risk for bleeding issues, especially after surgeries, minor injuries, or certain invasive procedures.<br><br>2. <strong>Petechiae or Purpura:</strong> Spontaneous bleeding into the skin can appear as small red or purple spots (petechiae) and larger areas of bruising (purpura), due to the buildup of blood under the skin that does not clot properly.<br><br>3. <strong>Bruising:</strong> Areas of the skin can bruise more easily and easily than normal, giving the appearance of unexplained bruising.<br><br>4. <strong>Bleeding gums:</strong> Deterioration of the gums, possibly leading to loss of teeth.<br><br>5. <strong>Heavy Menstrual Bleeding:</strong> In women, heavy or prolonged menstrual periods can also be a symptom.<br><br>6. <strong>Easy Epistaxis (Nosebleeds):</strong> Frequent or severe nosebleeds can occur without any apparent cause like a known injury.<br><br>7. <strong>Prolonged Bleeding:</strong> Easy bruising, cuts, or minor wounds that take a long time to stop bleeding can be a sign of low platelet counts.<br><br>Causes of thrombocytopenia include:<br><br>- <strong>Autoimmune disorders:</strong> Conditions like ITP, (immune thrombocytopenic purpura), SLE (systemic lupus erythematosus), and Rheumatoid Arthritis.<br> <br>- <strong>Pregnancy:</strong> The immune system of the mother may recognize the baby's platelets as foreign, leading to antibodies that cause the destruction of baby's platelets.<br> <br>- <strong>Medications:</strong> Certain drugs known as heparin, and acidic medications can interfere with the bone marrow production of platelets.<br> <br>- <strong>Infection:</strong> Certain viral infections, such as HIV or for CVDD drugs became fraught with actual clinical thrombosis in their users.<br> <br>- <strong>Lung Conditions:</strong> CLL (chronic lymphocytic leukemia), or certain cancers that elevate the WI CHE estrogen abdominal sat Drumuele MI NBO reaching
Thrombocytopenic refers to a medical condition characterized by a low platelet count in the blood, often resulting in an increased risk of bleeding or bruising.
Thrombocytopoiesis refers to the process of forming and developing platelets, which are small blood cells that play a crucial role in blood clotting. It is a complex process that involves the production of platelets from hematopoietic stem cells in the bone marrow, through a series of maturation steps, before they are released into the bloodstream.
Thromboelastography is a medical diagnostic test used to evaluate the viscoelastic properties of blood clotting. It measures the cooperativity of coagulation, or how well the various clotting factors work together to produce a blood clot. The test is based on the principles of rotational tests and measures the change in the physical properties of the clot as it forms.
Relating to the formation of a blood clot (thrombus) in a vein or artery that breaks loose and travels to another part of the body, where it can block circulation and cause a serious medical condition, often leading to a stroke or heart attack.
A blood clot (thrombus) that breaks loose and travels through the bloodstream until it lodges in a narrower part of a blood vessel, blocking the flow of blood. This condition can occur in the brain, lungs, heart, or other parts of the body and can be life-threatening.
Thromboembolic refers to the formation of a blood clot (thrombus) that breaks loose, travels through the bloodstream, and lodges in another part of the body, causing a blockage (embolism).<br><br>In medical terms, a thromboembolism occurs when a blood clot forms in a vein or an artery and travels through the bloodstream until it gets stuck, blocking normal blood flow to an organ or tissue.<br><br>Examples:<br><br> Pulmonary embolism: a blood clot in the lungs<br> Cerebral embolism: a blood clot in the brain<br> Deep vein thrombosis (DVT): a blood clot in the deep veins of the legs
Thrombogenesis refers to the formation or creation of a blood clot. It's a crucial process in the body, but excessive or abnormal thrombogenesis can lead to various health issues such as cardiovascular diseases, strokes, and pulmonary embolism.
Thrombogenic refers to the tendency of a substance, surface, or event to induce the formation of a blood clot (thrombus). In other words, it's the capacity to promote the creation of a blood clot, which can lead to blockages in blood vessels and potentially cause serious health problems, such as thrombosis or ischemia. This term is often used in medical and biomedical contexts to describe materials, devices, or situations that may increase the risk of blood clotting.
The term "thrombogenicity" refers to the tendency of a substance or material to promote the formation of thrombi (blood clots) or thrombosis, i.e., the process of blood clotting. In medical and scientific contexts, thrombogenicity is often discussed in terms of the risk of venous or arterial thrombosis, and is associated with various factors such as materials, devices, and drugs that may interact with the blood coagulation cascade.<br><br>In a broader sense, thrombogenicity can also refer to the ability of a material to cause blood clotting or thrombosis in a biological system, such as a wound or an implant.
Thrombokinase is an enzyme involved in the process of blood clotting. It activates prothrombin, a protein in the blood, to form thrombin, which then converts fibrinogen into fibrin to form blood clots.